Verismo Therapeutics Unveils New SynKIR-310 AACR Data
PHILADELPHIA, April 21, 2026 Verismo Therapeutics has unveiled compelling preclinical and early clinical findings for SynKIRâ„¢-310, its investigational multi-chain...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
PHILADELPHIA, April 21, 2026 Verismo Therapeutics has unveiled compelling preclinical and early clinical findings for SynKIRâ„¢-310, its investigational multi-chain...
LOUISVILLE, Kentucky, June 22, 2026 US WorldMeds has announced that the U.S. Food and Drug Administration (FDA) has granted...
CAMBRIDGE, Mass., June 20, 2026 Takeda and Boltz PBC have entered into a strategic collaboration aimed at accelerating the...
HONG KONG, June 15, 2026 Akeso, Inc. has announced the enrollment of the first patient in the Phase Ib/II...
BOSTON, June 15, 2026 Bambusa Therapeutics has announced positive preliminary results from the multiple ascending dose (MAD) cohorts of...
SOUTH SAN FRANCISCO, Calif., June 15, 2026 IDEAYA Biosciences has announced the initiation of a Phase 1/2 clinical combination...
TAMPA, Fla., June 15, 2026 TuHURA Biosciences, Inc. has announced the filing of an Investigational New Drug (IND) application...
STOCKHOLM, Sweden, June 13, 2026 Johnson & Johnson has announced groundbreaking results from the pivotal Phase 3 MonumenTAL-3 clinical...
CAMBRIDGE, Massachusetts, ROTTERDAM, Netherlands, and SHANGHAI, China, June 14, 2026 Harbour BioMed has secured a major legal victory in...
WILMINGTON, Del. & SAN MATEO, Calif., May 20, 2026 Incyte and Genesis Molecular AI have announced a significant expansion...
